AstraZeneca shares rise as China probe update reassures
Investors were reassured after the drugmaker said a potential fine in China would have only a minor business impact.The ...
Vanguard is making it even cheaper to invest in ETFs. Why investors should take note.
Investment giant Vanguard is taking up the next leg of the race to 0% fees for investors, this time in ETFs - MarketWatch ...